Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 17, 2019

SELL
$11.43 - $15.12 $133,925 - $177,161
-11,717 Closed
0 $0
Q1 2019

Oct 17, 2019

BUY
$5.98 - $13.98 $70,067 - $163,803
11,717 New
11,717 $145,000
Q3 2018

Oct 05, 2018

SELL
$9.5 - $13.75 $298,566 - $432,135
-31,428 Closed
0 $0
Q2 2018

Jul 17, 2018

BUY
$12.85 - $18.45 $132,830 - $190,717
10,337 Added 49.01%
31,428 $426,000
Q1 2018

Apr 17, 2018

BUY
$12.5 - $19.75 $22,700 - $35,866
1,816 Added 9.42%
21,091 $374,000
Q4 2017

Jan 18, 2018

BUY
$11.55 - $20.1 $87,491 - $152,257
7,575 Added 64.74%
19,275 $242,000
Q3 2017

Oct 23, 2017

BUY
$12.7 - $19.25 $148,590 - $225,225
11,700
11,700 $223,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.